Join
Live feed
·
INSIDERFilingvia Quantisnow
Kura Oncology Inc. logo

SVP, Finance & Accounting Doyle Thomas James sold $38,958 worth of shares (4,949 units at $7.87), decreasing direct ownership by 5% to 88,193 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
KURA· Kura Oncology Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track KURA (Kura Oncology Inc.) and more on Quantisnow.